Cargando…
Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis
Autores principales: | Castellano, Giuseppe, Infante, Barbara, Mercuri, Silvia, Forcella, Mauro, Cox, Sharon Natasha, Serviddio, Gaetano, Gesualdo, Loreto, Stallone, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525227/ https://www.ncbi.nlm.nih.gov/pubmed/32997331 http://dx.doi.org/10.1007/s40620-020-00872-4 |
Ejemplares similares
-
Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021) -
Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist
por: Uwatoko, Ryuta, et al.
Publicado: (2023) -
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021) -
Analysis of liver iron concentration in an elderly female undergoing hemodialysis with calcific uremic arteriolopathy does not support the role of iron overload in calciphylaxis: lesson for the clinical nephrologist
por: Rostoker, Guy, et al.
Publicado: (2021) -
Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient
por: Busutti, Marco, et al.
Publicado: (2022)